AbstractHIVVirological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of-Care in the ODYSSEY TrialView Abstract
AbstractHIVEarly Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African CountriesView Abstract
AbstractHIVPediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020View Abstract
AbstractHIVEfficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic ReviewView Abstract
AbstractHIVOnce-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 TrialView Abstract
AbstractHIVB/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in ToddlersView Abstract
AbstractHIVLong-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIVView Abstract
AbstractHIVPharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019View Abstract
AbstractHIVPharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE StudyView Abstract
AbstractHIVClinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South AfricaView Abstract
AbstractHIVWeight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY TrialView Abstract
AbstractHIVDolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-TanzaniaView Abstract
AbstractHIVLongitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South AfricaView Abstract
AbstractHIVHypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South AfricaView Abstract
AbstractHIVBone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 TrialView Abstract
AbstractHIVImpact of the COVID-19 pandemic on perinatal HIV prevention In Canada: Canadian Perinatal HIV Surveillance ProgramView Abstract
AbstractHIVA Comparative Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Pregnant and Breastfeeding Women and Their InfantsView Abstract
AbstractHIVThe Impact of COVID-19 on HIV Services for Children Living with HIV Across 14 CountriesView Abstract
AbstractHIVKnowledge and Perceptions of Covid-19 Among Young People Living With HIV in Malawi and the Impact of the Pandemic on Their Health and WellbeingView Abstract
AbstractHIVMore Frequent Viral Load Testing, With Point-Of-Care Tests Has No Impact on Viral Suppression in Postpartum HIV-Positive Women in a Randomized Controlled Trial in 2 Clinics in Johannesburg, South AfricaView Abstract
AbstractHIVUsability and Feasibility of an HIV POC Viral Load to Identify Infants at High Risk of MTCT at Birth in Primary Healthcare Clinics in MozambiqueView Abstract
AbstractHIVKey Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS ConsortiumView Abstract
AbstractHIVDeterminants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, LesothoView Abstract
AbstractHIVIncreased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-UnexposedView Abstract
AbstractHIVGrowth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in MalawiView Abstract
AbstractHIVThere is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, TanzaniaView Abstract
AbstractHIVPediatric ARV optimization in a real-world setting: Dolutegravir transition in MozambiqueView Abstract
AbstractHIVCo-trimoxazole prophylaxis for children born to mothers with HIV: predicted impact of different strategies on mortality up to the age of two yearsView Abstract
AbstractHIVRisk factors for post-discharge mortality following hospitalization for severe acute malnutrition in Zimbabwe and ZambiaView Abstract
AbstractHIVEstimated prevalence of prior HIV diagnosis among children living with HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia and Zimbabwe in the Population HIV Incidence Assessments (PHIA)View Abstract
AbstractHIVA Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in ZimbabweView Abstract
AbstractHIVRapid antiretroviral NNRTI-based initiation among youth living with HIV outcomes in the National AIDS program in ThailandView Abstract
AbstractHIVOptimizing antiretroviral treatment and viral suppression for adolescents and young people living with HIV by implementing Operation Triple Zero (OTZ) in four states in NigeriaView Abstract
AbstractHIVProjecting life expectancy for youth with non-perinatally- and perinatally-acquired HIV in the United StatesView Abstract
AbstractHIVHospitalisation rates for youth living with perinatally acquired HIV transitioning to adult careView Abstract
AbstractHIVIncreasing Capacity to Detect Neurocognitive Impairment among Adolescents and Young Adults with Perinatally Acquired HIV in Thailand: Validity of the NeuorScreen tablet application.View Abstract
AbstractHIVDevelopment of a transition readiness score for adolescents living with perinatally-acquired HIV and transitioning to adult careView Abstract
AbstractHIVParticipatory PMTCT: community engagement for co-created PMTCT programming in 2 districts of ZimbabweView Abstract
AbstractHIVPopulation-level risk factors for vertical transmission of HIV within the national prevention of mother-to-child transmission programme in South Africa: An ecological analysisView Abstract
AbstractHIVRisk factors for adverse pregnancy outcomes among pregnancy women living with HIV on ARTView Abstract
AbstractHIVPregnancy characteristics and outcomes among migrant women living with HIV recently arrived in the UKView Abstract
AbstractHIVFactors Associated with Recent HIV Infection Among Pregnant Women in Lilongwe, Malawi: A Case Control StudyView Abstract
AbstractHIVPrevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trialView Abstract
AbstractHIVTrends in characteristics and care of women diagnosed with HIV during pregnancy in the UKView Abstract
AbstractHIVFeasibility and acceptability of administering the cross culturally adapted ACTG adherence questionnaire to Ugandan women living with HIV via Audio Computer Assisted Self Interview (ACASI) vs via Provider-Assisted InterviewView Abstract
AbstractHIVBehavioural and Emotional Outcomes at 7 and 9 years in Children from the Children with HIV Early antiRetroviral (CHER) trial: A longitudinal investigationView Abstract
AbstractHIVAn assessment of multi-month dispensing of antiretroviral therapy for children and adolescents across 10 African countriesView Abstract
AbstractHIVA Systematic Review and Meta-Analysis of HIV Risk Screening Tools to Identify At-risk Children and Adolescents for HIV TestingView Abstract
AbstractHIVEarly-treated infants living with hiv typically recover their CD4+ T-cell counts but not their CD4+ T-cell percentagesView Abstract
AbstractHIVEffect of HIV on the distribution of NK cell subsets and their phenotype in infants pre-ART initiation and at 10 months of ageView Abstract
AbstractHIVRitonavir concentrations in hair predict virological outcomes in HIV-infected adolescents with virological treatment failure to atazanavir/ritonavir-based second-line treatmentView Abstract
AbstractHIVIMARA SA: Piloting a family-based HIV/STI prevention package for South African adolescent girls and young womenView Abstract
AbstractHIVUsing Narrative Films to Combat HIV-Related Stigma in Western Kenya: A Pilot Study of Adolescents Living with HIV and their CaregiversView Abstract
AbstractHIVTenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.View Abstract
AbstractHIVFeasibility and Acceptability of a Peer Youth Led Curriculum to Improve HIV Knowledge in Northern Tanzania: Resilience and Intervention Experience from the Perspective of Peer LeadersView Abstract
AbstractHIVTrends in HIV self-testing among adolescent and youth populations across sub-Saharan AfricaView Abstract
AbstractHIVLopinavir Drug Exposures in African Children with HIV using Lopinavir/ritonavir Pellets Dosed per WHO Weight-BandsView Abstract
AbstractHIVAssessing parental choice of Lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, Tanzania.View Abstract
AbstractHIVCaregivers perception on paedriatic Lopinavir/ritonavir formulations for HIV infected children at Baylor clinic, Mwanza-Tanzania.View Abstract
AbstractHIVElvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIVView Abstract
AbstractHIVEffect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trialView Abstract
AbstractHIVNeuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trialView Abstract
AbstractHIVMutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'IvoireView Abstract
AbstractHIVEarly Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan AfricaView Abstract
AbstractHIVHIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan AfricaView Abstract
AbstractHIVThe road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.View Abstract
AbstractHIVSuccessful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In KenyaView Abstract
AbstractHIVChallenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and TanzaniaView Abstract
AbstractHIVAdolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in KenyaView Abstract
AbstractHIVAdherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among CaregiversView Abstract
AbstractHIVThe Baylor International Pediatric AIDS Initiative (BIPAI) Network’s progress towards the second and third UNAIDS 95-95-95 goals among CALHIV receiving care in pediatric HIV centers in six countries in sub-Saharan Africa.View Abstract
AbstractHIVWhat are the drivers of improved viral suppression among HIV infected children (0-14 years)? Results from the national data warehouse in Kenya 2020View Abstract
AbstractHIVLow Viral Suppression among Children < 3 Years Old On Two Protease Inhibitor Formulations In Kenya, 2015-2019View Abstract
AbstractHIVIntensified technical assistance on multi-month dispensing of antiretroviral therapy to children and adolescents living with HIV resulted in achievement of the 85% PEPFAR benchmark in NigeriaView Abstract
AbstractHIV“I now always go out to play”: Evaluating the impact of the New Horizons Initiative for third-line HIV treatment for pediatric patients in Kenya, Uganda and Zambia.View Abstract
AbstractHIVOptimizing index testing of biological children of parents and siblings of children in care: Lesson learned from the ELMA project in Cote d’IvoireView Abstract
AbstractHIVReaching undiagnosed children living with HIV through index testing in Homa Bay, KenyaView Abstract
AbstractHIVImpact of a brief community health worker-administered index case testing screening tool on pediatric HIV case identification: early results from MalawiView Abstract
AbstractHIVAn Evaluation of Family Index Testing amongst Biological Children of People Living with HIV in NigeriaView Abstract
AbstractHIVHigh incidence of severe Respiratory Syncytial Virus’ infection among HIV-exposed uninfected infantsView Abstract
AbstractHIVAdvanced HIV disease among pregnant women at antenatal care enrolment in Southern MozambiqueView Abstract
AbstractHIVMissed opportunities for prevention of vertical HIV transmission and early infant antiretroviral treatment in EswatiniView Abstract
AbstractHIVThe impact of a couple-based intervention on one-year viral suppression among HIV-infected pregnant women and their male partners in Malawi: A Randomized Controlled TrialView Abstract
AbstractHIVTransitioning integrated antenatal PrEP delivery from research projects to routine clinic staff at 16 clinics in Western KenyaView Abstract
AbstractHIVHealth systems-level barriers and strategies for improved PrEP delivery for pregnant and postpartum women in Western KenyaView Abstract
AbstractHIVPregnancy and birth outcomes among young women living with perinatally acquired HIV in Thailand and VietnamView Abstract
AbstractHIVVaginal microbiota, genital inflammation and extracellular matrix remodelling collagenase: MMP-9 in pregnant women with HIV, a potential mechanism for excess preterm birth?View Abstract
AbstractHIVEarly antiretroviral therapy exposure associated risk of developmental disorder by school-aged and adolescent years among HIV-exposed uninfected children from UgandaView Abstract
AbstractHIVRisk factors for hospitalization among children who were HIV exposed and uninfected (cHEU) in Montreal, CanadaView Abstract
AbstractHIVFeeding practices and cost of diet of six-month-old HIV-exposed-uninfected compared to HIV-unexposed-uninfected infants in South-West Tshwane, South AfricaView Abstract
AbstractHIVThe effect of HIV and latent Tuberculosis infection during pregnancy on infant immune developmentView Abstract
AbstractHIVHigh adherence to pre-exposure prophylaxis in young men who have sex with men aged 16-24 years based on tenofovir diphosphate levels in ThailandView Abstract
AbstractHIVSelf-testing HIV positive and linking to treatment: A tale of resilience and fortitude among adolescent girls and young women in ZambiaView Abstract
AbstractHIVA Qualitative Examination of the Impacts of Perceived Stigma on the Mental Health of Adolescents Living with HIV in Western KenyaView Abstract
AbstractHIVMental Health Outcomes of an HIV-Prevention Program for South African Adolescent Girls and Young Women and their Female CaregiversView Abstract
AbstractHIV“Who am I going to stay with? Who will accept me?” – A qualitative study of family-level factors underlying disengagement from HIV care among Kenyan adolescentsView Abstract
AbstractHIVA Group-Based Mental Health Intervention for Youth Living with HIV in Northern Tanzania: Secondary Analyses of a Pilot TrialView Abstract
AbstractHIVInfluence of HO-1 Genotoype on Neurocognitive Functioning among Adolescents with Perinatally Acquired HIVView Abstract
AbstractHIV“You guide them but ultimately they make decisions”: Stakeholder insights about adolescent consent for HIV care and research in KenyaView Abstract
AbstractHIVOptimizing HIV and sexual and reproductive health care for adolescent girls and young women in Zambia: Qualitative findings from interviews and focus group discussionsView Abstract
AbstractHIVInfluences on Healthcare Worker Acceptability, Feasibility and Sustainability of an Adolescent Transition Package in KenyaView Abstract
AbstractHIVTelehealth and transition: Factors affecting telehealth and engagement in care during health care transition of adolescents and young adults with HIV during the COVID-19 pandemicView Abstract
AbstractHIVTimely pediatric regimen optimization at health facilities in Malawi is achievable despite COVID-19 pandemic restrictions with use of a virtual pediatric optimization toolkit and dedicated family ART clinic daysView Abstract
AbstractHIVThe impact of the COVID-19 pandemic on uptake of multi-month dispensing (MMD) of Antiretroviral Therapy (ART) for children living with HIV (CLHIV): A multicountry analysisView Abstract
AbstractHIVAccess to UK healthcare and viral control in adolescents and young adults living with perinatal HIV throughout 1 year of the SARS-CoV-2 pandemic.View Abstract
AbstractHIVSupporting Access to HIV Prevention and Care for Children and Youth during the COVID-19 Pandemic with Telemedicine and RideshareView Abstract
AbstractHIVDifferences in SARS-CoV-2 specific antibody production among adults vs. children living with HIVView Abstract
AbstractHIVHealth care worker experiences with COVID-19 in Kenya: personal protective equipment availability and service disruption for PrEP delivery for pregnant and postpartum womenView Abstract
AbstractHIVGaps in knowledge about COVID-19 in adolescents and young people in Sofala and TeteView Abstract
AbstractHIVDolutegravir-Based ART is Superior to Standard of Care in Young Children Living With HIVView Abstract
